July 14 (Reuters) - Emergent Biosolutions Inc:
* Emergent Biosolutions updates on terms of any termination of agreement related to acquisition of acam2000 business from Sanofi
* Emergent Biosolutions - agreement will become void and have no effect, except that certain specified obligations of Emergent and Sanofi shall survive
* Emergent Biosolutions - certain specified obligations of both parties shall survive including those concerning confidentiality and public announcements Source text - bit.ly/2vkeXkF Further company coverage:
Our Standards: The Thomson Reuters Trust Principles.